腫瘍循環器の臨床研究

Kadowaki H, Akazawa H, Ishida J, Komuro I. Mechanisms and management of immune checkpoint inhibitors-related cardiac adverse events. JMA J. 4(2):91-98,2021. doi: 10.31662/jmaj.2021-0001.

Kadowaki H, Ishida J, Akazawa H , Yagi H, Saga-Kamo A, Umei M, Matsuoka R, Liu Q, Matsunaga H, Maki H, Sato Y, Kume H, Komuro I. Axitinib induces and aggravates hypertension irrespectively of prior treatment with tyrosine kinase inhibitors. Circ Rep. 3(4):234-240,2021. doi: 10.1253/circrep.CR-21-0008.

Toru Oka, Hiroshi Akazawa H, Kazuhiro Sase, Kiyohiko Hatake, Issei Komuro. Cardio-Oncology in Japan: The Rapidly Rising Sun. JACC CardioOncology. 2(5): 815-818, 2020. doi:10.1016/j.jaccao.2020.10.014.

Issei Komuro, Chikashi Ishioka. Harmonization of Cardiovascular and Oncology and the Blooming of Cardio-Oncology in Japan. JACC CardioOncology. 2(5): 819-821, 2020. doi:10.1016/j.jaccao.2020.11.011

Hotaka Matsui, Taketo Kawai, Yusuke Sato, Junichi Ishida, Hiroshi Kadowaki, Yoshiyuki Akiyama, Yuta Yamada, Masaki Nakamura, Daisuke Yamada, Hiroshi Akazawa, Motofumi Suzuki, Issei Komuro, Haruki Kume. A fetal case of myocarditis following myositis induced by pembrolizumab treatment for metastatic upper urinary tract urothelial carcinoma. Int Heart J. 61(5): 1070-1074, 2020. doi:10.1536/ihj.20-162.

Hiroshi Kadowaki, Hiroshi Akazawa, Junichi Ishida, Issei Komuro. Cancer therapeutics-related cardiac dysfunction: insights from bench and bedside of onco-cardiology. Circ J. 84(9):1446-1453,2020. doi:10.1253/circj.CJ-20-0467.

Hiroyuki Kiriyama, Junichi Ishida, Hiroshi Kadowaki, Takeshi Iwasa, Arihiro Kiyosue, Satoshi Kodera, Jiro Ando, Hiroshi Akazawa, Issei Komuro. OCT-based management of nilotinib-associated CAD in a patient with chronic myeloid leukemia. JACC CardioOncology. 2019;1(2):318-321. doi: 10.1016/j.jaccao.2019.09.006.